ProKidney: Investor Update and Phase 3 Program Progress
PremiumCompany AnnouncementsProKidney: Investor Update and Phase 3 Program Progress
2M ago
ProKidney to discontinue PROACT 2, focus resources on PROACT 1
Premium
The Fly
ProKidney to discontinue PROACT 2, focus resources on PROACT 1
2M ago
ProKidney sees cash runway into mid-2026
Premium
The Fly
ProKidney sees cash runway into mid-2026
3M ago
ProKidney price target lowered to $6 from $15 at Jefferies
PremiumThe FlyProKidney price target lowered to $6 from $15 at Jefferies
5M ago
ProKidney Progresses in Kidney Disease Treatment Trials and Regulation
Premium
Company Announcements
ProKidney Progresses in Kidney Disease Treatment Trials and Regulation
5M ago
ProKidney announces ‘positive’ interim REGEN-007 Phase 2 trial data
Premium
The Fly
ProKidney announces ‘positive’ interim REGEN-007 Phase 2 trial data
5M ago
ProKidney Bolsters Leadership with Expert EVP, Enhances Operations
PremiumCompany AnnouncementsProKidney Bolsters Leadership with Expert EVP, Enhances Operations
8M ago
ProKidney appoints Ulrich Ernst as EVP, technical operations
Premium
The Fly
ProKidney appoints Ulrich Ernst as EVP, technical operations
8M ago
ProKidney reports FY23 EPS (57c), consensus (65c)
Premium
The Fly
ProKidney reports FY23 EPS (57c), consensus (65c)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100